表面等离子共振(SPR)生物传感器 2010

SPR Biosensing in crude serum using ultralow fouling binary patterned peptide SAM.

Analytical chemistry Bolduc OR, Pelletier JN, Masson JF
阅读原文 PDF DOI PubMed

组成图示

SPR Biosensing in crude serum using u... 传感器构成示意图

点击图片查看大图 · 依据论文自动绘制

传感器类型

表面等离子共振(SPR)生物传感器

检测对象

免疫球蛋白G(IgG)、基质金属蛋白酶-3(MMP-3);样品基质:PBS、未稀释牛血清(bovine serum)

检测原理

传感器以金SPR芯片为基底,3-MPA-HHHDD-OH肽通过N端巯基在金表面形成自组装单层,C端Asp羧基暴露。EDC/NHS将羧基活化为NHS酯,共价固定抗IgG或抗MMP-3抗体,乙醇胺封闭剩余位点。当PBS或牛血清中的IgG/MMP-3流过时,目标蛋白与抗体特异性结合,使SPR界面质量与局部折射率增加,引起共振角或波长偏移。响应大小随结合量增加而增大,在低浓度区近似线性,高浓度区受Langmuir等温线饱和影响。该设计无信号放大,依靠低污损肽单层抑制血清蛋白非特异吸附,使PBS校准可直接用于未稀释血清定量。

检测灵敏度

LOD: 1-10 pM(IgG,PBS);LOD: 3 pM(IgG低灵敏度区,图5);LOD: 0.11 nM(IgG高灵敏度区);LOD: 0.14 nM(MMP-3,PBS);线性范围: 0.5-50 nM(MMP-3);R^2 = 0.96(MMP-3);3σ = 0.03 nm(IgG LOD计算)

效应效果

3-MPA-HHHDD-OH单层对牛血清非特异吸附为32±5 ng/cm2,低于PEG约100 ng/cm2和CM-Dextran 829±46 ng/cm2;空白血清响应可忽略,表明抗干扰和稳定性良好。IgG传感器PBS检测限1-10 pM,优于或接近SERS、SPR、化学发光、ASV和LSPR等多步方法。MMP-3传感器PBS中LOD 0.14 nM,线性至50 nM;25 nM加标血清预测浓度32±2 nM,PBS预测30±2 nM,12.5 nM血清预测17±1 nM,1:1 PBS/血清预测12±4 nM,说明血清基质影响小。方法无需样品前处理、二抗或信号放大,适合复杂生物基质直接检测。

传感器的构成

  • 基底/换能器:金表面SPR芯片(Au SPR chip),提供表面等离子共振换能界面
  • 抗污修饰层:3-MPA-HHHDD-OH二元图案化肽自组装单层(SAM),N端3-MPA结合金,C端Asp羧基暴露,降低非特异吸附
  • 活化层:EDC/NHS,活化肽C端羧基形成NHS酯,用于共价固定抗体
  • 识别元件:抗人IgG或抗人MMP-3抗体(anti-human IgG / anti-human MMP-3),特异性结合目标蛋白
  • 封闭剂:1 M乙醇胺(ethanolamine,pH 8.5),封闭未反应位点
  • 样品基质:PBS或未稀释牛血清(bovine serum),提供IgG或MMP-3
  • 信号读出:SPR仪器(Kretchmann/Dove prism setup),记录结合引起的共振响应变化

中文摘要

本文报道了一种基于二元图案化肽自组装单层(SAM)的表面等离子共振(SPR)生物传感器,用于在未经处理的粗牛血清中直接检测基质金属蛋白酶-3(MMP-3)。作者筛选了多种3-MPA-Ax-By-OH肽,发现3-MPA-HHHDD-OH在抗非特异性吸附方面优于其他肽及聚乙二醇(PEG)。该肽N端以3-巯基丙酸(3-MPA)结合金表面,C端保留羧基,可经EDC/NHS化学共价固定抗体。基于该单层的IgG传感器在PBS中检测限为1-10 pM,与常见光学或电化学方法相当。进一步以抗MMP-3抗体构建传感器,PBS中MMP-3检出限为0.14 nM,线性范围可达50 nM;使用PBS校准曲线即可在未稀释牛血清中低纳摩尔定量MMP-3,且血清响应与PBS统计一致,空白血清非特异吸附可忽略。结果表明,二元图案化肽SAM适用于复杂生物基质中的直接生物传感。

英文摘要

Near-zero fouling monolayers based on binary patterned peptides allow low nanomolar detection of the matrix metalloproteinase-3 (MMP-3) directly in crude bovine serum, without sample pretreatment, secondary antibody detection or signal amplification. The peptide 3-MPA-HHHDD-OH (3-MPA, 3-mercaptopropionic acid) was found optimal compared to other binary patterned peptides based on 3-MPA-A(x)-B(y)-OH, where 0 <or= x, y <or= 5, and x + y = 5, and compared to PEG. In this study, amino acid A was His, Asp, Ser, or Leu, and amino acid B was His, Asp, or Ser. Zwitterionic peptides and other peptides exhibited excellent resistance to nonspecific adsorption. Binary patterned peptides were capped with 3-MPA on the N-terminus providing a monolayer with the C-terminus carboxylic acid available to subsequently immobilize antibodies. Thereby, an IgG biosensor demonstrated the efficiency of binary patterned peptides in SPR biosensing with a detection limit of 1-10 pM in PBS, similar to other optical or electrochemical techniques. This protocol was applied to establish a calibration curve for MMP-3, an analyte of clinical interest for many pathologies and a potential indicator of cancer. The LOD for MMP-3 was 0.14 nM in PBS, with a linearity of up to 50 nM. With the use of PBS calibration, MMP-3 was quantified at low nanomolar in undiluted bovine serum. The SPR response in serum was statistically the same as in PBS. A sensor exposed to blank serum exhibited negligible nonspecific adsorption. Hence, binary patterned peptides are suitable for biosensing directly in complex biological matrixes.